Gilead Opts Out of Deal for Arcus Cancer Therapy
Moderna Rises 8% Even as Barclays Downgrades
Ionis Pharmaceuticals Q4 2024 Earnings Preview
Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings
Innate Pharma and Merus Gets FDA Breakthrough Therapy Designation for Their Respective Treatments
Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges